Update to hepatitis C review

Kidney International

Volumn 85, Issue 5, 2014, Pages 1238-1239

  Fabrizi, Fabrizio ^a,b   Messa, Piergiorgio ^a   Martin, Paul ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACH 1625; ALISPORIVIR; BOCEPREVIR; CYCLOPHILIN A; DACLATASVIR; DANOPREVIR; FALDAPREVIR; FILIBUVIR; LEDIPASVIR; MERICITABINE; MICRORNA 122; MIRAVIRSEN; OMBITASVIR; PEGINTERFERON; RIBAVIRIN; SETROBUVIR; SIMEPREVIR; SOFOSBUVIR; SOVAPREVIR; TEGOBUVIR; TELAPREVIR; UNCLASSIFIED DRUG; VALOPICITABINE; VANIPREVIR; ANTIVIRUS AGENT;

ANEMIA; ANTIVIRAL THERAPY; ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FAILURE; LETTER; LOW DRUG DOSE; METABOLIC DISORDER; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; STEATOSIS; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT RESPONSE; RENAL INSUFFICIENCY, CHRONIC;

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84899707971     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.50     Document Type: Letter

References (4)

1. Barding GA Jr, Salditos R, Larive CK. Quantitative NMR for bioanalysis and metabolomics. Anal Bioanal Chem 2012; 404: 1165-1179.
2. Nicholson JK, Holmes E, Kinross JM et al. Metabolic phenotyping in clinical and surgical environments. Nature 2012; 491: 384-392.
3. Weiss RH, Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2011; 8: 22-33.
4. Posada-Ayala M, Zubiri I, Martin-Lorenzo M et al. Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease. Kidney Int 2014; 85: 103-111.